---
title: "Socioeconomic inequalities in adolescent cannabis use: role of access and risk perception"
id: "medrxiv-0-socioeconomic-inequalities-in-cannabis-use-among-european-adolescents-the-role"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-socioeconomic-inequalities-in-cannabis-use-among-european-adolescents-the-role"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1?rss=1"
published_at: "2026-09-06T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Socioeconomic inequalities in adolescent cannabis use: role of access and risk perception
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-socioeconomic-inequalities-in-cannabis-use-among-european-adolescents-the-role
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1?rss=1)
- **Published At:** 2026-09-06T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This cross-sectional analysis used 2019 ESPAD survey data from students aged **15–17 years** in **35 European countries** to examine socioeconomic (SES) differences in cannabis consumption. - Outcomes modelled were **regular cannabis use** (defined as ≥10 times in the past month) and past-year **high-risk/problematic use**. - Parental education (maternal and paternal) was the SES indicator; models adjusted for age, sex, and country. - Lower paternal education was associated with higher odds of regular use (OR 1.55, 95% CI 1.20–2.0) and high-risk use (OR 1.77, 95% CI 1.49–2.11); similar associations were observed for maternal education. - The study tested two mediating/moderating factors: perceived **cannabis availability** and perceived **risk of harm**. - Including perceived availability increased the likelihood of higher use among adolescents with lower SES, linked to their lower perceived availability in the sample. - Adjusting for **risk perception** removed the statistical significance of SES factors for regular use and reduced odds ratios for high-risk use by about 40–50%. - Authors interpret that SES inequalities in perceived risk largely explain the SES gap in both regular and high-risk cannabis use among worse-off adolescents. - The paper warns that policies shaping perceptions of cannabis risk may unintentionally widen SES inequalities if they affect risk perception differently across socioeconomic groups. - Data availability: underlying ESPAD data are available on reasonable request to the ESPAD group; this analysis was a secondary analysis of anonymous data and did not require new ethical approval according to the authors.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=JLgWjS_UJ59rUTHnd2Fo5UFr_fgInSZMoXZytM2sK1Q-1788697933.4282565-1.2.1.1-K8TOBU1peSOMP93UlpigCqIrcwtiaggcz0x3MIQeTLJ4aWP1JdUiGFHkrpAsnPuB) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Socioeconomic inequalities in cannabis use among European adolescents: the role of access and risk perception [ View ORCID Profile](http://orcid.org/0000-0001-6634-9000)Julian Perelman, Marcia Cardoso, Joana Alves, [ View ORCID Profile](http://orcid.org/0000-0002-8148-0928)Claudia Palladino doi: https://doi.org/10.64898/2026.09.01.26361911 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Julian Perelman 1 NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Julian%2BPerelman%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Perelman%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJulian%2BPerelman%2B) * [ORCID record for Julian Perelman](http://orcid.org/0000-0001-6634-9000 "Open in new tab") * For correspondence: jperelman@ensp.unl.pt Marcia Cardoso 2 Unidade de Saude Publica - Unidade Local de Saude de Castelo Branco, Portugal; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marcia%2BCardoso%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cardoso%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMarcia%2BCardoso%2B) Joana Alves 1 NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joana%2BAlves%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Alves%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJoana%2BAlves%2B) Claudia Palladino 3 Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Claudia%2BPalladino%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Palladino%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AClaudia%2BPalladino%2B) * [ORCID record for Claudia Palladino](http://orcid.org/0000-0002-8148-0928 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1293845/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1293845/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1293845/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1293845/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1293845/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1293845/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Introduction There is evidence that regular and high-risk-consumption is more prevalent among adolescents with a lower socioeconomic family status (SES). Yet, the causes for the SES gap remain unclear. We postulate that SES inequalities in regular and high-risk cannabis use among adolescents are mediated by differences in risk perception and access. Methods This cross-sectional study used data from a survey to students aged 15-17 years from 35 European countries in 2019 (European School Survey Project on Alcohol and Drugs). We modelled current regular use (≥10 times in the past month) and past-year high-risk/problematic use as a function of maternal and paternal education, adjusting for age, sex, and country, then further adjusting for moderating variables: perceived cannabis availability and perceived risk of harm. Results Lower paternal education was related to both higher regular and high-risk use (OR: 1.55 (1.20-2.0) and OR: 1.77 (1.49-2.11), respectively. A similar pattern was observed with maternal educational level. Including mediating factors, perceived availability increased the likelihood of higher use among adolescents with lower SES, related to their lower perceived availability. In contrast, adjusting for risk perception, SES factors lost significance for regular use and reduced OR by 40 to 50% for high-risk use. Conclusion Results indicate that SES inequalities in perceived risk explain the SES gap in regular and high-risk cannabis use among the worse-off. Attention should be paid to policies that may foster the perception that cannabis is risky, which may aggravate dangerous consumption among the worse-off, contributing to larger SES inequalities. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: European School Survey Project on Alcohol and Drugs (ESPAD) data use consent N. 2022_03_005. This study did not require ethical approval or informed consent, as it is a secondary analysis of data that was previously collected on an anonymous basis. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the ESPAD group. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.01.26361892v1 "Baseline intratumoral TCRbeta; and TCRgamma; repertoires predict response to immune checkpoint inhibitors in advanced renal cell carcinoma") Posted September 06, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/04/2026.09.01.26361911.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.09.01.26361911v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/04/2026.09.01.26361911.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Socioeconomic inequalities in cannabis use among European adolescents: the role of access and risk perception Julian Perelman, Marcia Cardoso, Joana Alves, Claudia Palladino medRxiv 2026.09.01.26361911; doi: https://doi.org/10.64898/2026.09.01.26361911 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361911v1%26text%3DSocioeconomic%2520inequalities%2520in%2520cannabis%2520use%2520among%2520European%2520adolescents%253A%2520the%2520role%2520of%2520access%2520and%2520risk%2520perception "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361911v1%26t%3DSocioeconomic%2520inequalities%2520in%2520cannabis%2520use%2520among%2520European%2520adolescents%253A%2520the%2520role%2520of%2520access%2520and%2520risk%2520perception "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361911v1%26title%3DSocioeconomic%2520inequalities%2520in%2520cannabis%2520use%2520among%2520European%2520adolescents%253A%2520the%2520role%2520of%2520access%2520and%2520risk%2520perception%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361911v1%26title%3DSocioeconomic%2520inequalities%2520in%2520cannabis%2520use%2520among%2520European%2520adolescents%253A%2520the%2520role%2520of%2520access%2520and%2520risk%2520perception "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.01.26361911) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.01.26361911v1&count=horizontal&via=&text=Socioeconomic%20inequalities%20in%20cannabis%20use%20among%20European%20adolescents%3A%20the%20role%20of%20access%20and%20risk%20perception&counturl=www.medrxiv.org/content/10.64898/2026.09.01.26361911v1 "Tweet This") ## Subject Area * [Public and Global Health ](https://www.medrxiv.org/collection/public-and-global-health) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (615) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (897) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (327) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4778) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (476) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (410) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (645) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1617) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15857) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1196) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6999) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (728) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1059) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5002) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1429) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1744) * [Hematology](https://www.medrxiv.org/collection/hematology) (583) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1338) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16256) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1163) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (665) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (721) * [Neurology](https://www.medrxiv.org/collection/neurology) (7211) * [Nursing](https://www.medrxiv.org/collection/nursing) (365) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1074) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1234) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1002) * [Oncology](https://www.medrxiv.org/collection/oncology) (3581) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1043) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (394) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (448) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (466) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (704) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1783) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (733) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (759) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5849) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9707) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2395) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1436) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1245) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (635) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (769) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (577) * [Surgery](https://www.medrxiv.org/collection/surgery) (770) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (303) * [Urology](https://www.medrxiv.org/collection/urology) (288) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of t
## Related Clinical Research

- [Reanalysis of Prenatal Acetaminophen and Neurodevelopmental Disorders Using Bias-Correction Methods](https://medichelpline.com/clinical-feed/medrxiv-0-testing-claimed-associations-of-prenatal-acetaminophen-with-neurodevelopmental.md)
- [Genetics of Childhood Eating Behaviors and Their Contribution to Obesity Risk](https://medichelpline.com/clinical-feed/medrxiv-8-genetic-and-behavioural-architecture-of-childhood-eating-behaviour-and-links-to.md)
- [How pediatricians build trust with vaccine-hesitant parents — a practice of last resort](https://medichelpline.com/clinical-feed/stat-news-3-the-pediatricians-who-take-in-vaccine-skeptical-parents-others-won-t.md)
- [North West London Diabetes Cohort: multiethnic EHR resource for diabetes complications research](https://medichelpline.com/clinical-feed/bmj-open-2-large-scale-multiethnic-electronic-health-record-resource-for-diabetes.md)
- [PLGA-gelatin nanofibrous scaffold with Vitex negundo and Jatropha multifida for diabetic wound hea](https://medichelpline.com/clinical-feed/pubmed-42701137.md) (DOI: 10.1007/s10735-026-10903-2)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.